25 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 25 of 25 clinical reviews.
A physician-reviewed, evidence-based breakdown of how BPC-157 pentadecapeptide affects appetite, hunger signaling, and food cravings, including mechanism, animal data, and what patients report in practice.
A physician-reviewed clinical overview of BPC-157 pentadecapeptide in autoimmune disease contexts, covering mechanisms, evidence, risks, and prescribing considerations for 2024.
A clinician-level review of BPC-157 pentadecapeptide and its effects on bone healing, density, and remodeling, covering animal trial data, proposed mechanisms, compounding status, and what patients should realistically expect.
A clinician-level review of BPC-157 pentadecapeptide and cancer risk. Covers angiogenesis data, tumor-promotion signals, FDA regulatory status, and what patients starting compounded BPC-157 need to know before their first injection.
A clinical review of BPC-157 pentadecapeptide cardiovascular effects, covering angiogenesis, arrhythmia, blood pressure, nitric oxide signaling, and what long-term animal and limited human data reveal for prescribers and patients.
A clinical review of BPC-157 pentadecapeptide and its effects on cognition, neuroprotection, and brain function. Covers mechanisms, animal data, compounding status, and what patients should realistically expect.
A physician-reviewed comparison of compounded BPC-157 pentadecapeptide versus branded formulations, covering purity, dosing, regulatory status, mechanisms, and what the available clinical evidence actually shows.
A GRADE-graded review of BPC-157 (pentadecapeptide) evidence covering animal data, the absence of human RCTs, FDA regulatory status, and what physicians need to know before prescribing this 503A compounded peptide.
A clinician-level review of BPC-157 pentadecapeptide and its reported effects on hair growth and skin healing, covering mechanisms, animal trial data, compounding regulations, and what patients should realistically expect.
A physician-reviewed analysis of BPC-157 pentadecapeptide and its effects on liver function, covering animal data, proposed mechanisms, safety signals, and where compounded BPC-157 stands clinically.
A clinician-level review of BPC-157 pentadecapeptide and its effects on mood, anxiety, depression, and CNS function. Covers mechanism, animal data, compounding status, and what patients should realistically expect.
A clinician-level review of BPC-157 pentadecapeptide and its proposed effects on metabolism, thermogenesis, and energy expenditure, covering mechanism, animal data, human evidence gaps, and compounding context.
A clinician-level review of BPC-157 pentadecapeptide microdosing protocols, covering animal pharmacokinetics, compounding status, proposed dose ranges, and the hard limits of current human evidence.
A clinician-level review of BPC-157 pentadecapeptide for muscle preservation: mechanisms, dosing protocols, safety data, and where the evidence stands in 2025.
A physician-level guide to diagnosing and fixing BPC-157 non-response: dose adjustment, injection-site selection, peptide quality, cycling protocols, and adjunct strategies, all backed by primary literature.
A clinician-level review of BPC-157 pentadecapeptide for post-bariatric surgery patients, covering mechanism, gut-healing data, dosing, safety, and current compounding status.
A physician-level guide to the BPC-157 pre-surgery hold window, covering pharmacology, anesthesia interactions, wound-healing effects, and current clinical recommendations for compounded pentadecapeptide use.
Does stopping BPC-157 cause rebound symptoms? A physician-reviewed deep dive into the pharmacology, animal data, and clinical considerations around BPC-157 pentadecapeptide discontinuation.
A clinician-level review of BPC-157 pentadecapeptide and the kidneys: preclinical renal protection data, proposed mechanisms, toxicology signals, and what compounding patients need to know before starting.
When and how to safely restart BPC-157 pentadecapeptide after an acute illness. Covers hold criteria, restart dosing, drug interactions, and what limited human data exist.
A physician-reviewed guide to BPC-157 pentadecapeptide seasonal use considerations, covering tissue-repair mechanisms, dosing protocols, storage stability, and current regulatory status.
A clinical deep-dive into how BPC-157 pentadecapeptide may affect sexual function, covering the proposed mechanisms, animal-model data, the absence of human RCTs, dosing considerations, and what compounding regulations mean for patients today.
A physician-reviewed deep dive into how BPC-157 pentadecapeptide may alter sleep architecture, dopamine-serotonin signaling, and REM/NREM cycling, with primary-literature citations and a frank appraisal of the human data gap.
How to time, store, and adjust BPC-157 pentadecapeptide doses across time zones and travel days. MD-level review of dosing schedules, peptide stability, circadian pharmacology, and what the current animal literature actually shows.
A week-by-week clinical guide to BPC-157 (pentadecapeptide) covering what patients and clinicians can realistically expect during the first 30 days, with primary-literature citations and dose context.